Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis.

Reza Sari MotlaghShahrokh F Shariat Tatsushi Kawada Ekaterina LaukhtinaPawel RajwaAbdulmajeed AydhFrederik KönigMaximilian PallaufNicolai A HuebnerPascal A BaltzerPierre I KarakiewiczAxel Heidenreich Shahrokh F Shariat

Published in: Prostate cancer and prostatic diseases (2022)

The performance of SelectMDx is comparable to that of mpMRI with regards to PCa and HG-PCa detection. In addition, this biomarker could help refine the clinical decision-making regarding the necessity of a biopsy in patients suspected to has been PCa.

Keyphrases

prostate cancer
systematic review
decision making
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
radical prostatectomy
peritoneal dialysis
randomized controlled trial
patient reported outcomes
loop mediated isothermal amplification
label free
quantum dots